BCAT1 and colorectal carcinoma: We report a prospective longitudinal observational study aimed to determine if BCAT1/IKZF1 methylation testing of patients, who had completed initial treatment with curative intent for CRC stage I‐III, could identify patients most likely to develop recurrence.